Impact Factor
3.43
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.24
302 total citations
h5-index
21
h5 depth signal
Cited share
84.7%
83 of 98
Total citations
302
Citation footprint
Metric signal
4.03
External metric anchor
Self-citation
0.3%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Iran
245
India
90
United States
31
China
29
Turkey
29
Citing Fields of Research
Drug Delivery Systems
120
Phytochemicals
65
Pharmacology & Toxicology
55
Diabetes
35
Oncology
31
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
829
Articles tracked across the journal lifetime
Indexed publication set
98
83 cited publications
Last 12 months
89
7.4 publications/month
Open access share
9.0%
8 OA publications in the last year
Leading citing country
Iran
245 citing publications
Leading citing field
Drug Delivery Systems
120 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v22n1, 2014-
v18, 2010-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Phytochemicals
Nanoparticles
Oncology
Cancer, Autophagy & Apoptosis
Cancer & Development
Issuing & Sponsoring Bodies
Contributor
Dānishgāh-i ʻUlūm-i Pizishkī-i Tihrān. Dānishkadah-ʾi Dārūʹsazī
Broad Categories
Drug Therapy
Pharmacology
Drug Delivery Systems
Virology
Medical Ethics
Phytochemicals
Allergies
Metal Homeostasis
Molecular & Cellular Toxicology
MeSH Descriptors
Drug Therapy
Pharmaceutical Preparations
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
05
DOI 10.1007/s40199-026-00666-2
Open DOI
Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation
06
DOI 10.1007/s40199-026-00671-5
Open DOI
Emerging nanostructured platforms for improved oral delivery of antidiabetic agents: overcoming physiological barriers and enhancing therapeutic efficacy
Background Diabetes mellitus, a chronic metabolic disorder affecting over 537 million individuals worldwide, represents one of the most burdensome global health challenges of the 21st century. Despite the availability of numerous oral an...
07
DOI 10.1007/s40199-026-00663-5
Open DOI
BAY-876 restores lenvatinib sensitivity in resistant hepatocellular carcinoma cells by disrupting the GLUT1–SLC7A11–NADPH redox axis
Background Acquired resistance limits the efficacy of lenvatinib in hepatocellular carcinoma (HCC). This study evaluated whether GLUT1 inhibition by BAY-876 reverses lenvatinib resistance by disrupting SLC7A11-associated redox buffering....
08
09
DOI 10.1007/s40199-026-00669-z
Open DOI
Colistin therapy and survival outcomes in neonatal carbapenem-resistant gram-negative sepsis
10
Bibliographical & Catalog Notes
Title on journal home page (as viewed on April 17, 2012): DARU journal of pharmaceutical sciences.
Description based on: Vol. 7, no. 3 (1999); title from cover.
Print issues ceased with v. 19, no. 6 (2011).
Also issued online.